Bloomage Biotechnology Corp Ltd
SSE:688363

Watchlist Manager
Bloomage Biotechnology Corp Ltd Logo
Bloomage Biotechnology Corp Ltd
SSE:688363
Watchlist
Price: 54 CNY -2.32% Market Closed
Market Cap: 26B CNY
Have any thoughts about
Bloomage Biotechnology Corp Ltd?
Write Note

Bloomage Biotechnology Corp Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bloomage Biotechnology Corp Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Bloomage Biotechnology Corp Ltd
SSE:688363
Total Equity
ÂĄ7B
CAGR 3-Years
9%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Equity
ÂĄ25.1B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Equity
ÂĄ12.4B
CAGR 3-Years
1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Equity
ÂĄ12.7B
CAGR 3-Years
71%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Equity
ÂĄ31.5B
CAGR 3-Years
26%
CAGR 5-Years
44%
CAGR 10-Years
29%
Imeik Technology Development Co Ltd
SZSE:300896
Total Equity
ÂĄ6.3B
CAGR 3-Years
12%
CAGR 5-Years
74%
CAGR 10-Years
N/A
No Stocks Found

Bloomage Biotechnology Corp Ltd
Glance View

Market Cap
26B CNY
Industry
Biotechnology

Nestled in the bustling corridors of the biotechnology industry, Bloomage Biotechnology Corp Ltd. has carved a niche as a leading player specializing in the production and innovation of biopolymers, with a particular emphasis on hyaluronic acid. Since its inception, the company has embraced a scientific approach combined with a robust business strategy, propelling it to the forefront of biotechnological advancements. Its operations are underpinned by a relentless pursuit of research and development, utilizing cutting-edge fermentation technology to manufacture high-quality hyaluronic acid that serves various industries such as cosmetics, food, and pharmaceuticals. Bloomage’s revenue model is intricately linked to the diverse applications of hyaluronic acid. By supplying raw materials to cosmetic giants, the company significantly taps into the lucrative beauty industry, as this compound is highly valued for its skin hydration properties. Additionally, Bloomage is involved in the healthcare segment, where it provides key ingredients for medical products that enhance joint health and accelerate wound healing. Through strategic partnerships and a focus on high-margin products, Bloomage not only diversifies its revenue streams but also sustains its position in competitive markets. This deliberate orchestration of science and commerce ensures the company remains at the vanguard of both innovation and profitability.

Intrinsic Value
65.56 CNY
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Bloomage Biotechnology Corp Ltd's Total Equity?
Total Equity
7B CNY

Based on the financial report for Sep 30, 2024, Bloomage Biotechnology Corp Ltd's Total Equity amounts to 7B CNY.

What is Bloomage Biotechnology Corp Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
27%

Over the last year, the Total Equity growth was 1%. The average annual Total Equity growth rates for Bloomage Biotechnology Corp Ltd have been 9% over the past three years , 27% over the past five years .

Back to Top